In contrast, the catalase and SOD levels in the in-remission WT, hypernephroma, and CCS pediatric patients’ groups were significantly increased after one year of chemotherapy compared to their levels before treatment (Table 3). This evidence concerns the gene CAT and renal cell carcinoma.